INCYTE CORP
INCY
36 insider filings · Latest: Jun 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | Jun 8 8:04 PM | Thomas TrayPrincipal Accounting Officer | Sale | 2,639 | $100.00 | $263.9K | 21,132(D) | View → |
| Jun 4, 2026 | Jun 4 8:03 PM | THOMAS R TRAY | Proposed Sale | 2,639 | $100.00 | $263.9K | — | View → |
| May 26, 2026 | May 28 8:03 PM | Thomas TrayPrincipal Accounting Officer | Sale | 2,051 | $97.35 | $199.7K | 21,132(D) | View → |
| May 26, 2026 | May 26 8:04 PM | THOMAS R TRAY | Proposed Sale | 2,051 | $97.35 | $199.7K | — | View → |
| May 19, 2026 | May 21 8:02 PM | Paul J ClancyDirector | Sale | 15,000 | $94.93 | $1.4M | 23,741(D) | View → |
| May 19, 2026 | May 19 8:21 PM | PAUL J. CLANCY | Proposed Sale | 15,000 | $94.93 | $1.4M | — | View → |
| Apr 17, 2026 | Apr 21 8:09 PM | Pablo J CagnoniPresident, Global Head of R&D | Sale | 18,667 | $96.50 | $1.8M | 262,692(D) | View → |
| Apr 17, 2026 | Apr 17 8:07 PM | PABLO CAGNONI | Proposed Sale | 18,667 | $96.50 | $1.8M | — | View → |
| Mar 17, 2026 | Mar 19 8:20 PM | Pablo J CagnoniPresident, R&D | Sale | 18,667 | $94.24 | $1.8M | 234,800(D) | View → |
| Mar 17, 2026 | Mar 17 8:07 PM | PABLO CAGNONI | Proposed Sale | 18,667 | $94.24 | $1.8M | — | View → |
| Feb 19, 2026 | Feb 23 9:05 PM | Pablo J CagnoniPresident, R&D | Sale | 18,668 | $100.91 | $1.9M | 234,800(D) | View → |
| Feb 19, 2026 | Feb 19 9:02 PM | PABLO CAGNONI | Proposed Sale | 18,668 | $100.91 | $1.9M | — | View → |
| Feb 9, 2026 | Feb 9 10:14 PM | VIJAY IYENGAR | Proposed Sale | 12,743 | $109.00 | $1.4M | — | View → |
| Jan 7, 2026 | Jan 7 9:01 PM | MOHAMED ISSA | Proposed Sale | 10,856 | $109.07 | $1.2M | — | View → |
| Jan 6, 2026 | Jan 6 9:05 PM | VIJAY IYENGAR | Proposed Sale | 95,811 | $104.35 | $10.0M | — | View → |
| Jan 5, 2026 | Jan 5 9:34 PM | VIJAY IYENGAR | Proposed Sale | 16,437 | $102.81 | $1.7M | — | View → |
| Jan 5, 2026 | Jan 5 9:06 PM | STEVEN STEIN | Proposed Sale | 15,634 | $101.70 | $1.6M | — | View → |
| Dec 19, 2025 | Dec 19 9:06 PM | VIJAY IYENGAR | Proposed Sale | 52,941 | $101.73 | $5.4M | — | View → |
| Dec 19, 2025 | Dec 19 9:05 PM | THOMAS R TRAY | Proposed Sale | 2,774 | $100.00 | $277.4K | — | View → |
| Dec 18, 2025 | Dec 18 9:12 PM | THOMAS R TRAY | Proposed Sale | 600 | $98.25 | $59.0K | — | View → |
Page 1 of 4
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 8, 2026 | Jun 10 8:41 PM | BAKER BROS. ADVISORS LPDirector, 10% Owner | Grant/Award | 12,222 | $100.64 | 6,111(I) | View → |
| Jun 8, 2026 | Jun 10 8:08 PM | Edmund HarriganDirector | Grant/Award | 6,111 | $100.64 | 6,111(D) | View → |
| Jun 8, 2026 | Jun 10 8:07 PM | Paul J ClancyDirector | Grant/Award | 6,111 | $100.64 | 6,111(D) | View → |
| Jun 8, 2026 | Jun 10 8:07 PM | Jacqualyn A FouseDirector | Grant/Award | 6,111 | $100.64 | 6,111(D) | View → |
| Jun 8, 2026 | Jun 10 8:06 PM | Jean Jacques BienaimeDirector | Grant/Award | 6,111 | $100.64 | 6,111(D) | View → |
| Jun 8, 2026 | Jun 10 8:05 PM | Katherine A HighDirector | Grant/Award | 6,111 | $100.64 | 6,111(D) | View → |
| Jun 8, 2026 | Jun 10 8:05 PM | Otis W BrawleyDirector | Grant/Award | 6,111 | $100.64 | 6,111(D) | View → |
| Jun 4, 2026 | Jun 8 8:04 PM | Thomas TrayPrincipal Accounting Officer | Option Exercise | 2,639 | $83.83 | 0(D) | View → |
| May 26, 2026 | May 28 8:03 PM | Jean Jacques BienaimeDirector | Option Exercise | 15,000 | $84.53 | 0(D) | View → |
| May 19, 2026 | May 21 8:02 PM | Paul J ClancyDirector | Option Exercise | 15,000 | $84.53 | 0(D) | View → |
| May 8, 2026 | May 11 8:45 PM | BAKER BROS. ADVISORS LPDirector, 10% Owner | Option Exercise | 30,000 | $84.53 | 0(I) | View → |
| May 4, 2026 | May 6 8:34 PM | Suketu UpadhyayEVP & Chief Financial Officer | Grant/Award | 51,600 | $97.14 | 26,342(D) | View → |
| Apr 17, 2026 | Apr 21 8:09 PM | Pablo J CagnoniPresident, Global Head of R&D | Option Exercise | 18,667 | $71.93 | 27,699(D) | View → |
| Mar 17, 2026 | Mar 19 8:20 PM | Pablo J CagnoniPresident, R&D | Option Exercise | 18,667 | $64.25 | 32,910(D) | View → |
| Feb 19, 2026 | Feb 23 9:05 PM | Pablo J CagnoniPresident, R&D | Option Exercise | 18,668 | $61.76 | 16,268(D) | View → |
| Jan 16, 2026 | Jan 21 9:06 PM | Pablo J CagnoniPresident, R&D | Grant/Award | 28,475 | $106.21 | 28,475(D) | View → |
| Jan 16, 2026 | Jan 21 9:06 PM | Steven H SteinEVP & Chief Medical Officer | Grant/Award | 19,932 | $106.21 | 19,932(D) | View → |
| Jan 16, 2026 | Jan 21 9:06 PM | Mohamed Khairie IssaEVP, Head of US Oncology | Grant/Award | 14,237 | $106.21 | 14,237(D) | View → |
| Jan 16, 2026 | Jan 21 9:05 PM | Matteo TrottaEVP, GM, Dermatology US | Grant/Award | 8,542 | $106.21 | 8,542(D) | View → |
| Jan 16, 2026 | Jan 21 9:04 PM | Thomas TrayPrincipal Accounting Officer | Grant/Award | 2,425 | $106.21 | 2,425(D) | View → |
Page 1 of 2
Next →